24th Edition of Conference on World Cardiology

Dr. Adamu Ishaku^*
*Correspondence: Dr. Adamu Ishaku, Department of Microbiology Faculty of Natural and Applied Sciences Nasarawa State University, Nigeria, Email:

Cardiology is a branch of drug managing issue of the heart is it human or creature. The field incorporates medicinal determination and treatment of intrinsic heart surrenders, coronary vein infection, heart disappointment, valvular coronary illness and electrophysiology. Doctors who have practical experience in this field of pharmaceutical are called cardiologists, a claim to fame of inward prescription.

The global market for cardiac medical devices was valued at nearly $49.4 billion in 2013 and $52 billion in 2014. This market is projected to reach nearly $67.5 billion by 2019, with a compound annual growth rate (CAGR) of 5.3% from 2014 to 2019

Cardiac monitoring and diagnostic market size in Asia in 2015 is 4.5$ bn, in 2017 it increases to 6$ bn with growth rate of 8%, and it will reach 12$ bn by 2023

Cardiac surgery and interventional cardiology are two major segments that make up the cardiovascular disease (CVD) market. Cardiac surgery is focused on cardiovascular procedures involving the repair or replacement of the heart, its valves, bypassing damages or occluded vessels, and other procedures to improve the functions of the cardiovascular system with a wide variety of devices. Interventional cardiology is focused on minimally invasive treatments for structural and functional heart disease using catheter-based approaches. Generally, these procedures include devices such as catheters, guide wires, and stents and so on.

Stents occupy the dominant share among all the devices used in interventional cardiology worldwide. The technological advances in the field of medicine and surgery have led to inventions such as bio-absorbable or biodegradable stents which are currently largely being used in interventional cardiac surgeries, thereby being one of the primary factors driving the global surgical and interventional cardiology devices market.

Cardiology (Devices and Technology) - Global Trends, Estimates and Forecasts, 2012-2018 statistical surveying report says worldwide interventional cardiology market is assessed to achieve US$22.2 billion by 2016. Cardiovascular industry development keeps on expanding with the nearness of numerous advances, for example, propelled material and programming which is highlighted in a large portion of the cardiology gadgets. So Cardiology meeting will be an awesome achievement now a days as the mindfulness for the treatment of cardiovascular infections is exceptionally vital among the general population and all will come to think about the

The global Cardiology Surgical & Interventional Cardiology market was valued at $XXbn in 2015 and is growing at a CAGR of around XX% through 2020.

The US is the largest market for Cardiology Surgical & Interventional Cardiology devices owing to factors such as high healthcare expenditures, patient awareness levels and sophisticated healthcare infrastructure. On the contrary, APAC is expected to show largest growth in the market owing to the presence of high unmet medical needs mainly coming from China and Japan. The increasing prevalence of cardiovascular diseases is the leading factor driving the market. Other factors contributing to the market growth include aging population, sedentary lifestyle and changing dietary habits, innovations in the field cardiology as well as the rise in number of interventional cardiologists, and increasing demand for minimally invasive surgical techniques.

The global cardiology surgical & interventional cardiology devices market is dominated by stents and the global market for the stents used in cardiovascular operations (coronary stents) has a dominant presence in the U.S. owing to the rapidly aging population in North America. It is followed by the European countries and Japan.

Samuel George

Program Coordinator | Cardiology 2020